ArticleBiology2026

Combined Exendin-4 and Rituximab Treatment Improves β-Cell Function and Delays Disease Progression in NOD Mice.

Yongbin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.